| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1978 | 1978 | ||||||||
|
CYP3A7-CYP3A51P readthrough | 0.821 | 0.154 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 1979 | |||||||||
|
BMS1 pseudogene 20 | 0.682 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1982 | 1982 | |||||||||
|
LDL receptor related protein associated protein 1 | 0.579 | 0.731 | 4.5E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1986 | 1986 | ||||||||
|
nuclear cap binding protein subunit 1 | 0.839 | 0.077 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
synaptosome associated protein 25 | 0.489 | 0.808 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
olfactory receptor family 10 subfamily A member 4 | 0.540 | 0.808 | 1.7E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
taste 2 receptor member 18 pseudogene | 1.000 | 0.038 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | |||||||||
|
PAXIP1 associated glutamate rich protein 1 | 0.597 | 0.808 | 0.74 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
immunoglobulin heavy constant alpha 1 | 0.617 | 0.692 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1989 | 1989 | |||||||||
|
acylaminoacyl-peptide hydrolase | 0.666 | 0.577 | 5.0E-13 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 1990 | 1990 | ||||||||
|
PDZ domain containing 2 | 0.666 | 0.538 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1991 | 1991 | ||||||||
|
ubiquitin conjugating enzyme E2 B | 0.644 | 0.615 | 0.20 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
involucrin | 0.626 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
RAB2A, member RAS oncogene family | 0.722 | 0.385 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1993 | 1993 | ||||||||
|
Ral GTPase activating protein non-catalytic subunit beta | 0.659 | 0.577 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1993 | 1993 | ||||||||
|
X-ray sensitivity | 0.716 | 0.500 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1988 | 1994 | |||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | |||||||||
|
ABR activator of RhoGEF and GTPase | 0.650 | 0.500 | 0.63 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
norrin cystine knot growth factor NDP | 0.566 | 0.692 | 0.65 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
orosomucoid 1 | 0.608 | 0.731 | 1.1E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
pantothenate kinase 1 | 0.743 | 0.308 | 2.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 |